APPA to file NDA this September. LGND PDUFA set for November. FLML NDA due this year. XNPT offering + CYTR

Jul 26, 2012 No Comments by

A.P. Pharma, Inc. (OTCBB: APPA.OB) announced that it now hopes to re-file its NDA of APF530, for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting, during September 2012. The company had previously given guidance of a filing during “mid-2012″. The company also said it has issued 102m shares at $0.525 per share, resulting in gross proceeds of approximately $53.6 million.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner GlaxoSmithKline (NYSE: GSK) has been granted priority review from the FDA for the supplemental new drug application for Promacta to treat thrombocytopenia in adult patients with chronic hepatitis C virus (HCV) infection. A press release from GSK was released on May 30, 2012, regarding the sNDA filing, resulting in a PDUFA date of on or about November 30, 2012, under a 6-month priority review.

Flamel Technologies (NASDAQ: FLML) today said it remains on track to file its first NDA during 2012.

CytRx Corporation (NASDAQ: CYTR) announced the initiation of a Phase 1b clinical trial of aldoxorubicin (formerly INNO-206) administered in combination with the commonly used chemotherapeutic agent doxorubicin in patients with advanced solid tumors who have failed other therapies.

XenoPort, Inc. (Nasdaq:XNPT) announced the pricing of an underwritten offering of 6,153,846 shares of its common stock at a price to the public of $6.50 per share, for gross proceeds of $40m.

Daily News

About the author

Currently residing in New Zealand and employed in the education industry, Mr. A. Burden holds a M.Com in International Business from the University of Sydney and used these skills together with his passion for investing to establish BioPharmCatalyst in June 2010 as a tool for investing decisions in the US pharmaceutical market. He spends much of his free time mountain biking, playing squash and hiking.
No Responses to “APPA to file NDA this September. LGND PDUFA set for November. FLML NDA due this year. XNPT offering + CYTR”

Leave a Reply